Weixia Zhong Selected Research

GR 73632

12/2019	Δ9-THC and related cannabinoids suppress substance P- induced neurokinin NK1-receptor-mediated vomiting via activation of cannabinoid CB1 receptor.
5/2014	Broad-spectrum antiemetic efficacy of the L-type calcium channel blocker amlodipine in the least shrew (Cryptotis parva).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weixia Zhong Research Topics

Disease

17	Vomiting 06/2021 - 01/2014
5	Neoplasms (Cancer) 06/2021 - 01/2009
4	Nausea 05/2021 - 01/2017
1	Body Weight (Weight, Body) 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2017
1	Neoplasm Metastasis (Metastasis) 09/2012
1	Adenocarcinoma 09/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2012
1	Lymphatic Metastasis 01/2009

Drug/Important Bio-Agent (IBA)

14	AntiemeticsIBA 06/2021 - 01/2014
10	Palonosetron (Aloxi)FDA Link 06/2021 - 01/2014
10	EmeticsIBA 06/2021 - 04/2015
8	netupitantIBA 06/2021 - 04/2015
8	Serotonin (5 Hydroxytryptamine)IBA 06/2021 - 01/2014
8	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2014
7	Substance PIBA 06/2021 - 01/2014
7	Nifedipine (Adalat)FDA LinkGeneric 06/2021 - 01/2014
6	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 06/2021 - 01/2014
5	Dopamine (Intropin)FDA LinkGeneric 06/2021 - 01/2014
4	Dantrolene (Dantrium)FDA LinkGeneric 01/2021 - 01/2014
3	U 0126 (UO 126)IBA 06/2021 - 01/2021
3	Neurotransmitter Agents (Neurotransmitter)IBA 05/2021 - 01/2014
3	bisindolylmaleimide IIBA 01/2021 - 09/2018
3	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2021 - 04/2016
3	CannabinoidsIBA 01/2020 - 01/2017
3	CalciumIBA 01/2017 - 01/2014
3	FPL 64176IBA 01/2017 - 01/2014
3	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 04/2016 - 01/2014
3	Amlodipine (Norvasc)FDA LinkGeneric 05/2015 - 01/2014
2	QuinpiroleIBA 01/2021 - 05/2014
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 01/2021 - 09/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2012
2	resiniferatoxinIBA 01/2020 - 01/2014
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2019 - 01/2017
2	GR 73632IBA 12/2019 - 05/2014
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 09/2018 - 01/2014
2	ThapsigarginIBA 01/2017 - 04/2016
2	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 05/2015 - 01/2014
2	LigandsIBA 09/2012 - 01/2009
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2022
1	gastric inhibitory polypeptide receptorIBA 01/2022
1	Glycogen Synthase Kinase 3IBA 06/2021
1	MK 2206IBA 06/2021
1	N- (4- methoxybenzyl)- N'- (5- nitro- 1,3- thiazol- 2- yl)ureaIBA 06/2021
1	SB 216763IBA 06/2021
1	perifosineIBA 06/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 06/2021
1	Sulpiride (neogama)IBA 01/2021
1	Type C PhospholipasesIBA 01/2021
1	Protein Kinase CIBA 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2021
1	2,4,6- trimethyl- N- (meta- 3- trifluoromethylphenyl)benzenesulfonamideIBA 01/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2021
1	1- (6- ((3- methoxyestra- 1,3,5(10)- trien- 17- yl)amino)hexyl)- 1H- pyrrole- 2,5- dioneIBA 01/2021
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2021
1	Copper Sulfate (Sulfate, Copper)FDA Link 01/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 12/2019
1	RimonabantIBA 12/2019
1	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 12/2019
1	CB2 Cannabinoid ReceptorIBA 12/2019
1	Tropisetron (Navoban)IBA 08/2017
1	pranlukastIBA 08/2017
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 08/2017
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 08/2017
1	LeukotrienesIBA 08/2017
1	palosentron drug combination netupitantIBA 01/2017
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 01/2017
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	ProdrugsIBA 04/2016
1	Inositol (Myoinositol)IBA 04/2016
1	4- methyl- 4'- (3,5- bis(trifluoromethyl)- 1H- pyrazol- 1- yl)- 1,2,3- thiadiazole- 5- carboxanilideIBA 04/2016
1	Serotonin ReceptorsIBA 04/2016
1	RyanodineIBA 04/2016
1	TachykininsIBA 04/2015
1	Phosphotransferases (Kinase)IBA 04/2015
1	Protein Kinases (Protein Kinase)IBA 04/2015
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 04/2015
1	Protein Kinase C-alphaIBA 04/2015
1	(4- (m- Chlorophenylcarbamoyloxy)- 2- butynyl)trimethylammonium ChlorideIBA 05/2014
1	Pilocarpine (Ocusert)FDA LinkGeneric 05/2014
1	Apomorphine FDA Link 05/2014
1	Ruthenium RedIBA 01/2014
1	Capsaicin (Zostrix)FDA Link 01/2014
1	Viral ProteinsIBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Ion Channels (Ion Channel)IBA 01/2014
1	capsazepineIBA 01/2014
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2014
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2014
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2014
1	Mitogen-Activated Protein Kinase 3IBA 01/2014
1	KN 93IBA 01/2014
1	2-methyl-5-HTIBA 01/2014
1	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2012

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2017
2	Drug Therapy (Chemotherapy) 09/2018 - 01/2017
1	Glycemic Control 01/2022